05/15/2024 8:29 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 4:27 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
04/12/2024 3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 7:37 PM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024 7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024 3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
03/01/2024 3:40 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:23 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:44 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 2:53 PM | Eagle Pharmaceuticals (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024 7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by) Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024 8:15 AM | Eagle Pharmaceuticals (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024 4:09 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 1:04 PM | Eagle Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:00 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:01 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 6:00 PM | Eagle Pharmaceuticals (Issuer) Graves Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
12/20/2023 3:34 PM | Cahill Brian Joseph (Reporting) Eagle Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 4:11 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 3:26 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 6:36 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 6:39 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 4:23 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/09/2023 6:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:39 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 4:41 PM | Eagle Pharmaceuticals (Issuer) Graves Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 7:49 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 6:10 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 4:07 PM | Eagle Pharmaceuticals (Issuer) Tarriff Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 3:48 PM | Eagle Pharmaceuticals (Subject) Tarriff Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 6:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 5:55 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
How this is some devastating news (Ad) Check out this report real quick…
It’s full proof that most people barely have enough money to cover the monthly expenditures…
Let alone save for retirement or plan the next vacation.
At the risk of sounding political…
If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better…
You might be waiting for a long long time.
But what if…?
What if there was a way to completely turn the tables? But I can promise that you’ll see all the details for yourself here. |
08/08/2023 6:06 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 5:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 7:43 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2023 7:23 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |